Yesterday I testified on Capitol Hill in Washington D.C. about fentanyl and China, before the U.S.-China Economic and Security Review Commission, a bipartisan, bicameral congressional-advisory commission. I spoke about my findings from Fentanyl, Inc., in particular that China is subsidizing the production and export of fentanyl and fentanyl-like drugs. You can read more information about the hearing here, and even watch it on C-SPAN. It was a bit nervewracking but also exciting, as it was the first time I’d revealed my findings publicly, that China offers tax rebates and other subsidies for the drugs that are fueling the opioid epidemic in the U.S. and elsewhere.